Back
Macquarie Tax-Free USA Short Term ETF Vs. Cidara Therapeutics Industry Stock Comparison
Sell
44
STAX
Macquarie Tax-Free USA Short Term ETF
Last Price:
$25.36
Seasonality Move:
1.92%
Buy
72
CDTX
Cidara Therapeutics
Last Price:
$50.58
Seasonality Move:
-8.55%
Sell
44
Macquarie Tax-Free USA Short Term ETF (STAX)
is a Sell
Is Macquarie Tax-Free USA Short Term ETF a Buy, Sell or Hold?
-
The current Macquarie Tax-Free USA Short Term ETF [STAX] share price is $25.39. The Score for STAX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
STAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.54. The Score for CDTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STAX Stock Price Chart
What is Macquarie Tax-Free USA Short Term ETF's stock price today?
-
The Macquarie Tax-Free USA Short Term ETF share price today is $25.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STAX is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
STAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.65 | Buy |
Relative Strength Index (14 RSI): | 68.69 | Buy |
Chaikin Money Flow: | -1176 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.27 - 25.37) | Buy |
Bollinger Bands (100): | (25.16 - 25.36) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.75 | Buy |
Relative Strength Index (14 RSI): | 77.36 | Buy |
Chaikin Money Flow: | 24640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.19 - 50.39) | Buy |
Bollinger Bands (100): | (16 - 35.28) | Buy |
STAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.36 | Buy |
20-day SMA: | 25.33 | Buy |
50-day SMA: | 25.25 | Buy |
200-day SMA: | 25.31 | Buy |
8-day EMA: | 16.1 | Buy |
20-day EMA: | 8.38 | Buy |
50-day EMA: | 3.75 | Buy |
200-day EMA: | 1 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.6 | Buy |
20-day SMA: | 40.9 | Buy |
50-day SMA: | 30.03 | Buy |
200-day SMA: | 21.62 | Buy |
8-day EMA: | 49.1 | Buy |
20-day EMA: | 42.88 | Buy |
50-day EMA: | 33.88 | Buy |
200-day EMA: | 23.66 | Buy |
Macquarie Tax-Free USA Short Term ETF Earnings Growth & STAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Macquarie Tax-Free USA Short Term ETF Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |